Hydroxyapatite is the mineral of bone and teeth, used as an oral calcium source containing bone proteins or as a toothpaste crystal. Spinal mineral loss is slower than with calcium carbonate when trial results are combined, and fractures have not been shown to fall. Toothpaste finds fewer cavities than a paste with no active ingredient and about the same rates as fluoride, plus less cold and touch sensitivity. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood calcium | 9.0–10.0 mg/dL | Catches high or low calcium |
| 25-hydroxyvitamin D | 40–60 ng/mL | Low vitamin D limits absorption |
| PTH | 15–50 pg/mL | High values can mean calcium lack or gland disease |
| Kidney filtration (eGFR) | Above 90 mL/min/1.73 m² | The mineral load is cleared by the kidney |
| Spine BMD | Above −1.0, or stable versus the person's own baseline | Shows whether mineral density is holding |
| Bone-turnover marker | No fixed target; track change from one's own baseline | Shows whether breakdown or formation is shifting |
Cadence: Fasting morning panel before oral use (blood calcium with albumin, phosphate, kidney filtration, 25-hydroxyvitamin D, and PTH); toothpaste alone does not require blood tests. A prior kidney stone is a reason to add a 24-hour urine calcium when that test is available. Repeat blood calcium, kidney filtration, and vitamin D at 3 months, then every 6–12 months, and sooner if thirst, constipation, or flank pain appears. Bone-density scan at 18–24 months. Tooth sensitivity and new cavities are reviewed at dental visits about every 6 months.